Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy

Robert Dennert, Sebastiaan Velthuis, Dirk Westermann, Dirk Donker, Simon Schalla, Robert Jan Van Suylen, Stephane Heymans*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Fulminant myocarditis is a rare inflammatory heart disease affecting relatively young adults. We describe a case of a 27-year-old male with acute onset severe heart failure. A rapid and accurate diagnostic approach suggested parvovirus B19 as the most probable cause for this fulminant viral myocarditis. Initial haemodynamic support, intensive immunosuppressive and antiviral therapy resulted in a complete recovery within 2 weeks. This case demonstrates the importance of a detailed diagnosis, allowing better classification of the underlying pathology and subsequent targeted treatment.
Original languageEnglish
Pages (from-to)681-685
Number of pages5
JournalAntiviral Therapy
Volume15
Issue number4
DOIs
Publication statusPublished - 24 Sep 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy'. Together they form a unique fingerprint.

Cite this